You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TIM-3

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumor Trial in China (TQB2618 injection and TQB2450 injection)

Recruiting
  • Advanced Solid Tumor
  • TQB2618 injection and TQB2450 injection
  • Fuzhou, Fujian, China
  • +4 more
Dec 1, 2022

Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)

Terminated
  • Metastatic Melanoma
  • Tumor Infiltrating Lymphocytes
  • Nivolumab and Ipilimumab
  • New Haven, Connecticut
    Yale New Haven Hospital
Jul 20, 2022

Neuroimaging, Quality Control Trial in Ghent (Magnetic Resonance Imaging)

Completed
  • Neuroimaging
  • Quality Control
  • Magnetic Resonance Imaging
  • Ghent, Belgium
    Ghent University
Nov 30, 2021

Solid Tumor Trial in Belgium, Japan, United States (LY3415244)

Terminated
Has Results
  • Solid Tumor
  • Boston, Massachusetts
  • +5 more
Oct 21, 2021

Autoimmune Diseases, Multiple Sclerosis Trial in Amman (LPX-TI641)

Not yet recruiting
  • Autoimmune Diseases
  • Multiple Sclerosis
  • Amman, Jordan
    Triumpharma
May 11, 2023

Advanced Esophageal Squamous Cell Carcinoma Trial in China (TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin,

Not yet recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • TQB2618 injection, Penpulimab injection, Paclitaxel, Cisplatin
  • +2 more
  • Tongling, Anhui, China
  • +9 more
Apr 18, 2023

Advanced Solid Tumors Trial in Hangzhou (TQB2618 injection)

Unknown status
  • Advanced Solid Tumors
  • TQB2618 injection
  • Hangzhou, Zhejiang, China
    Cancer Hospital of The University of Chinese Academy of Sciences
Nov 8, 2020

Postoperative Prevention of Tumor Trial in Shanghai (Oral NMN combined with DC cell vaccine)

Not yet recruiting
  • Postoperative Prevention of Tumor
  • Oral NMN combined with DC cell vaccine
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Sep 6, 2023

MRI Assessment of Leukemia Response to Therapy

Completed
  • Acute Myelogenous Leukemia
  • 3 Tesla (3T) Siemens Total imaging matrix (TIM) Trio whole-body system
  • Portland, Oregon
    Oregon Health and Science University
Jul 27, 2019

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute Trial in Worldwide (Decitabine, PDR001, MBG453)

Active, not recruiting
  • Leukemia
  • +7 more
  • Boston, Massachusetts
  • +10 more
Jan 19, 2023

Acute Myeloid Leukemia (AML), High-risk Myelodysplastic Syndrome (MDS) Trial in Worldwide (HDM201, MBG453, Venetoclax)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • High-risk Myelodysplastic Syndrome (MDS)
  • Durham, North Carolina
  • +8 more
Dec 13, 2022

Nasopharyngeal Carcinoma Trial in China (TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride

Recruiting
  • Nasopharyngeal Carcinoma
  • TQB2618 Injection, Pempulimab Injection, Cisplatin Injection, Gemcitabine Hydrochloride Injection
  • +2 more
  • Guangzhou, Guangdong, China
  • +3 more
Nov 28, 2022

NSCLC Trial in Guangzhou (Hypofractionated radiotherapy, induction chemo-immunotherapy, concurrent chemo)

Recruiting
  • Non-small Cell Lung Cancer
  • Hypofractionated radiotherapy
  • +4 more
  • Guangzhou, Guangdong, China
    Sun yat-sen university cancer center
Nov 14, 2023

Recurrent/Refractory Acute Myeloid Leukemia, MDS Trial in ChengDu (TQB2618 injection azacitidine, AZA decitabine, DAC)

Recruiting
  • Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
  • TQB2618 injection azacitidine, AZA decitabine, DAC
  • ChengDu, Sichuan, China
    West China Hospital of Sichuan University
Jun 16, 2022

Breast Cancer Trial in Istanbul (Soluble immune checkpoints)

Recruiting
  • Breast Cancer
  • Soluble immune checkpoints
  • Istanbul, Turkey
  • +1 more
Jul 14, 2022

Crosstalk Between Mucosal-Associated Invariant T Cells and Gut

Recruiting
  • Type1diabetes
  • MAIT cells analysis
  • +4 more
  • Antony, France
  • +1 more
Aug 2, 2022

Immune Dysregulation in Patients With COVID-19

Recruiting
  • COVID-19
  • Immunosuppression
  • mid covid-19 patients
  • Jinan, Shandong, China
    Qilu Hospital of Shandong University
Jan 6, 2023

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in Worldwide (Trilaciclib, Placebo, Gemcitabine)

Active, not recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • Birmingham, Alabama
  • +111 more
Oct 25, 2022

Response to Influenza Vaccination in Pediatric Oncology Patients

Recruiting
  • Hematologic Malignancy
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 17, 2022

    Stroke, Multiple Sclerosis, Parkinson Disease Trial in Lucerne (smart sensor egg training)

    Recruiting
    • Stroke
    • +2 more
    • smart sensor egg training
    • Lucerne, Switzerland
      Luzerner Kantonsspital
    Sep 28, 2023

    Advanced Malignancies Trial in Worldwide (MBG453, PDR001, Decitabine)

    Terminated
    • Advanced Malignancies
    • Baltimore, Maryland
    • +13 more
    Sep 20, 2022

    Neoadjuvant Therapy in Rectal Cancer

    Recruiting
    • Rectal Cancer
    • Immune checkpoint measure
    • Istanbul, Turkey
      Istanbul Training and Research Hospital
    Jul 9, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Candiolo (inulin, Pembrolizumab, Nivolumab)

    Recruiting
    • Head and Neck Squamous Cell Carcinoma
    • inulin
    • +2 more
    • Candiolo, Turin, Italy
      Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo
    Apr 7, 2023

    A Qualitative Investigation of CLEAT Participants

    Not yet recruiting
    • Osteoarthritis
    • Qualitative Investigation of Participant Experiences
    • (no location specified)
    Jul 6, 2023

    LY007 for r/r B-NHL and Exploration of Novel CAR-T Translational

    Not yet recruiting
    • Relapsed Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 19, 2023